JP2007522094A5 - - Google Patents

Download PDF

Info

Publication number
JP2007522094A5
JP2007522094A5 JP2006527154A JP2006527154A JP2007522094A5 JP 2007522094 A5 JP2007522094 A5 JP 2007522094A5 JP 2006527154 A JP2006527154 A JP 2006527154A JP 2006527154 A JP2006527154 A JP 2006527154A JP 2007522094 A5 JP2007522094 A5 JP 2007522094A5
Authority
JP
Japan
Prior art keywords
kinase
drug
hexokinase
complex
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006527154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007522094A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/031147 external-priority patent/WO2005030258A2/en
Publication of JP2007522094A publication Critical patent/JP2007522094A/ja
Publication of JP2007522094A5 publication Critical patent/JP2007522094A5/ja
Abandoned legal-status Critical Current

Links

JP2006527154A 2003-09-22 2004-09-22 小分子組成物、及びその組成物を使用して薬物効率を高めるための方法 Abandoned JP2007522094A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50532503P 2003-09-22 2003-09-22
US58183504P 2004-06-22 2004-06-22
PCT/US2004/031147 WO2005030258A2 (en) 2003-09-22 2004-09-22 Small molecule compositions and methods for increasing drug efficiency using compositions thereof

Publications (2)

Publication Number Publication Date
JP2007522094A JP2007522094A (ja) 2007-08-09
JP2007522094A5 true JP2007522094A5 (de) 2007-12-06

Family

ID=34396244

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006527154A Abandoned JP2007522094A (ja) 2003-09-22 2004-09-22 小分子組成物、及びその組成物を使用して薬物効率を高めるための方法

Country Status (5)

Country Link
EP (1) EP1689439A2 (de)
JP (1) JP2007522094A (de)
AU (1) AU2004275770A1 (de)
CA (1) CA2539914A1 (de)
WO (1) WO2005030258A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CN1315862C (zh) 2000-05-26 2007-05-16 艾登尼科斯(开曼)有限公司 处理黄病毒和瘟病毒的方法和组合物
CA2506129C (en) 2002-11-15 2015-02-17 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
WO2007076160A2 (en) * 2005-12-28 2007-07-05 Acidophil Llc C-10 carbamates of taxanes
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
KR101919093B1 (ko) * 2008-05-23 2018-11-16 더 유니버시티 오브 브리티쉬 콜롬비아 리포좀 나노입자에 사용하기 위한 변형된 약물
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカAcademia Sinica Ptfe様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
JP6302909B2 (ja) 2012-08-18 2018-03-28 アカデミア シニカAcademia Sinica シアリダーゼの同定および画像化のための細胞透過性プローブ
WO2014033617A1 (en) 2012-08-31 2014-03-06 Novartis Ag 2'-ethynyl nucleoside derivatives for treatment of viral infections
WO2014078463A1 (en) 2012-11-19 2014-05-22 Merck Sharp & Dohme Corp. 2 -alkynyl substituted nucleoside derivatives for treating viral diseases
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
EP3013347B1 (de) * 2013-06-27 2019-12-11 Academia Sinica Glykankonjugate und verwendung davon
EP3041484B1 (de) 2013-09-06 2021-03-03 Academia Sinica Humane inkt-zell-aktivierung mittels glykolipiden mit veränderten glycosylgruppen
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
CA2937123A1 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
EP3129767B1 (de) 2014-03-27 2021-09-01 Academia Sinica Reaktive markierungsverbindungen und ihre verwendungen
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR20170005142A (ko) 2014-05-27 2017-01-11 아카데미아 시니카 증진된 항체 효능을 위한 범용 당형태에 관한 조성물 및 방법
EP3149037A4 (de) 2014-05-27 2018-01-10 Academia Sinica Anti-her2-glykoantikörper und verwendungen davon
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-cd20 글리코항체 및 이의 용도
TWI732738B (zh) 2014-05-28 2021-07-11 中央研究院 抗TNF-α醣抗體及其用途
KR102422375B1 (ko) 2014-09-08 2022-07-18 아카데미아 시니카 당지질을 사용한 인간 iNKT 세포 활성화
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
WO2016118191A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
US10336784B2 (en) 2016-03-08 2019-07-02 Academia Sinica Methods for modular synthesis of N-glycans and arrays thereof
US10538592B2 (en) 2016-08-22 2020-01-21 Cho Pharma, Inc. Antibodies, binding fragments, and methods of use
KR20210021984A (ko) 2018-05-15 2021-03-02 인터크 펩타이드 테라퓨틱스 리미티드 펩타이드 활성화 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59083A (en) * 1979-01-10 1983-12-30 Israel Marcus Pharmaceutical composition containing thymidine and a salicyclic acid derivative as a solubilizing agent therefor
US5608049A (en) * 1995-03-10 1997-03-04 Bristol-Myers Squibb Company Preparation of d4T from 5-methyluridine
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds

Similar Documents

Publication Publication Date Title
JP2007522094A5 (de)
JP2007520565A5 (de)
JP2007302683A5 (de)
JP2004516265A5 (de)
JP2003503454A5 (de)
NO20053245D0 (no) Tabletter med modifisert frigjoring av bupropionhydroklorid.
DE602004017510D1 (de) Medizinprodukt vom kapseltyp
JP2009524695A5 (de)
MA28489B1 (fr) Preparations pharmaceutiques
FR2910473B1 (fr) Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
NO332405B1 (no) Forbindelse av 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling, deres anvendelse til fremstilling av farmasoytiske midler for behandling av inflammatorisk sykdom og farmasoytisk preparat omfattende forbindelsen.
CL2007003690A1 (es) Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas.
WO2006095029A3 (en) Di-polymer protein conjugates and processes for their preparation
WO2007144169A3 (de) Entacapone-derivatives
WO2008006795A3 (en) Indole compounds
SI1718340T1 (sl) Novi efektorski konjugati, postopek za njihovo proizvodnjo in njihova farmacevtska uporaba
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
WO2007144699A3 (en) Process for the preparation of alfuzosin
EP1996732A4 (de) Erkennung und behandlung von sowie entdeckung von heilmitteln gegen mycobakterielle krankheiten
FR2873693B1 (fr) Derives d'amino-tropane, leur preparation et leur application en therapeutique
JP2005508892A5 (de)
IL184487A0 (en) N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application
FR2912404B1 (fr) Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate